Vercide, Danica Joy .

HRN: 27-87-19  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2025
CEFUROXIME 500MG (TAB)
09/28/2025
10/05/2025
PO
500 Mg
BID
S/P NSVD, Postpartum Hemorrhage (referral)
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: